Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19385786 | 0.67 | MAOA (0.33) | HSP90AA1 | |
| Hydrochloric Acid SCHEMBL667557 | 0.67 | HSP90AA1 (0.35) | HSP90AA1 | |
| SCHEMBL28070877 | 0.65 | HDAC8 (0.33) | — | |
| SCHEMBL19385802 | 0.65 | PARP1 (0.36) | HSP90AA1 | |
| SCHEMBL30917930 | 0.64 | ALDH1A1 (0.46) | HSP90AA1 | |
| Hydrochloric Acid SCHEMBL21222025 | 0.64 | ALDH1A1 (0.33) | — | |
| SCHEMBL21665187 | 0.64 | HSP90AA1 (0.38) | HSP90AA1 | |
| SCHEMBL19766534 | 0.64 | ALDH1A1 (0.39) | — | |
| SCHEMBL2015810 | 0.63 | TSHR (0.42) | — | |
| SCHEMBL31410536 | 0.63 | GRIN2D (0.37) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11242327-B2 | Analgesic compounds | RECURIUM IP HOLDINGS, LLC (US) | 2022-02-08 | — | — | US | disclosed |
| US-20200270221-A1 | ANALGESIC COMPOUNDS | KTHERA, LLC | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200270221-A1 | ANALGESIC COMPOUNDS | INA, IK, ACHE | HSP90AA1 1161/4885GRIN2D 614/4885GRIN3B 201/4885 |
| US-11242327-B2 | Analgesic compounds | INA, IK, ACHE | HSP90AA1 1161/4885GRIN2D 614/4885GRIN3B 201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.